fbpx
Prostate Patient Testimonial: JT’s story

 

Prostate cancer is the second most common cancer in African-American men.  According to the American Cancer Society, about one in seven men will be diagnosed with prostate cancer during his lifetime. John (JT) Newton was the one in seven.  The 59-year-old Illinois resident was diagnosed with prostate cancer in the late 1990s.  Mr. Newton underwent […]

 

Learn More

 

 

CyberKnife Treatment Helps Prostate Cancer Patient

 

September is National Prostate Cancer Awareness Month National Prostate Cancer Awareness Month is observed every September in the United States by health experts and advocates, and individuals concerned with men’s prostate health.  Designating a month for the disease serves the purpose of increasing public awareness of the importance of prostate health and screenings, educating about […]

 

Learn More

 

 

Metastatic Brain Tumor Patients Under 50 Show Improved Survival Rates with Stereotactic Radiosurgery

 

A recent study published in the International Journal of Radiation Oncology • Biology • Physics, the official journal of the American Society for Radiation Oncology (ASTRO), found that cancer patients with limited brain metastases who are under 50 years old could benefit from stereotactic radiosurgery (SRS) without whole brain radiation therapy (WBRT).  The study, “Phase […]

 

Learn More

 

 

Study Confirms Stereotactic Ablative Radiotherapy Effectiveness for Early-Stage Lung Cancer

 

According to research from a phase III randomized international study from The University of Texas MD Anderson Cancer Center, patients with operable stage I non-small cell lung cancer (NSCLC) could achieve better overall survival rates if treated with stereotactic ablative radiotherapy (SABR), also known as stereotactic body radiation therapy (SBRT), rather than the current standard […]

 

Learn More

 

 

Illinois CyberKnife Proudly Supports the Radiosurgical Research Institute

 

The Radiosurgical Research Institute (RRI), a 501c3 public charity, is the only independent medical research organization committed to improving the outcomes of cancer patients with radiosurgery.  Its mission is to advance radiosurgery as a cancer treatment through innovation, education, and quality research in collaboration with treatment centers around the world.   Before RRI, radiosurgical treatment […]

 

Learn More

 

 

The National Comprehensive Cancer Network® Supports SBRT for Prostate Cancer

 

The National Comprehensive Cancer Network recently updated their patient guide to support stereotactic body radiation therapy (SBRT) for prostate cancer.  The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 26 of the world’s leading cancer centers, is dedicated to improving the quality, efficiency, and effectiveness of care for patients with cancer.   NCCN aims […]

 

Learn More

 

 

Common CyberKnife Patient Questions

 

Read below for an overview of common CyberKnife® questions to learn more about the treatment. CyberKnife can treat brain tumors, lung tumors, prostate cancer, metastatic and recurrent cancer, and other types of cancerous and non-cancerous conditions. This is not intended as medical advice to replace the expertise and judgment of your health care team. It […]

 

Learn More

 

 

Illinois CyberKnife Joins Advocate Lutheran General to Celebrate Cancer Survivorship Day

 

Each year, we recognize the first Sunday in June as National Cancer Survivors Day, a time focused on celebrating cancer survivors, family members, friends and medical professionals. The awareness day, in its 28th year, is sponsored by the non-profit National Cancer Survivors Day Foundation and provides an opportunity for all people living with a history […]

 

Learn More

 

 

Men’s Health Week: ACS 2015 Prostate Cancer Stats

 

Celebrated each year as the week leading up to and including Father’s Day, Men’s Health Week aims to heighten awareness of preventable health problems and encourage early detection and treatment of disease among men. Aside from skin cancer, prostate cancer is the most common cancer in American men. It’s been reported that about 1 in […]

 

Learn More

 

 

Insurance Policy Update: Humana® Now Covers SBRT for Prostate Cancer

 

Humana recently announced it has updated its position on stereotactic body radiation therapy (SBRT) for prostate cancer.  Their coverage policy now covers SBRT treatment for early and intermediate stage prostate cancer. An announcement from the CyberKnife Coalition (CKC) stated “The CyberKnife Coalition is pleased to announce that effective May 28, 2015 early stage prostate cancer […]

 

Learn More